Choline metabolites: Gene by diet interactions

Current Opinion in Lipidology

Volumn 27, Issue 1, 2016, Pages 33-39

  Smallwood, Tangi ^a   Allayee, Hooman ^b   Bennett, Brian J ^a,c,d  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d The University of North Carolina at Chapel Hill   (United States)

Author keywords

choline; gene by diet interactions; polymorphisms

Indexed keywords

CHOLINE; DRUG METABOLITE; METHYLAMINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MTHFR PROTEIN, HUMAN; PEMT PROTEIN, HUMAN; PHOSPHATIDYLETHANOLAMINE METHYLTRANSFERASE; TRIMETHYLOXAMINE;

CLINICAL TRIAL (TOPIC); CONTROLLED CLINICAL TRIAL (TOPIC); DIET; EPIGENETICS; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; INTESTINE FLORA; META ANALYSIS (TOPIC); METABOLIC DISORDER; MICROBIOME; NONHUMAN; PREGNANCY OUTCOME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ANIMAL; GENETICS; METABOLISM;

ANIMALS; CHOLINE; HUMANS; METHYLAMINES; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE;

EID: 84954401404     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0000000000000259     Document Type: Review

References (54)

1. De Witt Stetten J, Juan Salcedo J. The effect of chain length of the dietary fatty acid upon the fatty liver of choline deficiency. J Nutr. 1945; 167-170.
2. da Costa KA, Kozyreva OG, Song J, et al. Common genetic polymorphisms affect the human requirement for the nutrient choline. FASEB J. 2006; 20: 1336-1344.
3. Shaw GM, Carmichael SL, Yang W, et al. Periconceptional dietary intake of choline and betaine and neural tube defects in offspring. Am J Epidemiol. 2004; 160: 102-109.
4. Hartiala J, Bennett BJ, Tang WH, et al. Comparative genome-wide association studies in mice and humans for trimethylamine N-oxide, a proatherogenic metabolite of choline and L-carnitine. Arterioscler Thromb Vasc Biol. 2014; 34: 1307-1313.
5. Bennett BJ, de Aguiar Vallim TQ, Wang Z, et al. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 2013; 17: 49-60.
6. Miller CA, Corbin KD, da Costa KA, et al. Effect of egg ingestion on trimethylamine-N-oxide production in humans: a randomized, controlled, dose-response study. Am J Clin Nutr. 2014; 100: 778-786.
7. ShawGM, Finnell RH, Blom HJ, et al. Choline and risk of neural tube defects in a folate-fortified population. Epidemiology. 2009; 20: 714-719.
8. Zeisel SH. Choline: critical role during fetal development and dietary requirements in adults. Annu Rev Nutr. 2006; 26: 229-250.
9. Shaw GM, Vollset SE, Carmichael SL, et al. Nested case-control study of onecarbon metabolites in mid-pregnancy and risks of cleft lip with and without cleft palate. Pediatr Res. 2009; 66: 501-506.
10. Silver MJ, Corbin KD, Hellenthal G, et al. Evidence for negative selection of gene variants that increase dependence on dietary choline in a Gambian cohort. FASEB J. 2015; 29: 3426-3435.
11. Pogribny IP, Kutanzi K, Melnyk S, et al. Strain-dependent dysregulation of onecarbon metabolism in male mice is associated with choline- And folatedeficient diet-induced liver injury. FASEB J. 2013; 27: 2233-2243.
12. Ivanov A, Nash-Barboza S, Hinkis S, Caudill MA. Genetic variants in phosphatidylethanolamine N-methyltransferase and methylenetetrahydrofolate dehydrogenase influence biomarkers of choline metabolism when folate intake is restricted. J Am Diet Assoc. 2009; 109: 313-318.
13. Kohlmeier M, da Costa KA, Fischer LM, Zeisel SH. Genetic variation of folatemediated one-carbon transfer pathway predicts susceptibility to choline deficiency in humans. Proc Natl Acad Sci U S A. 2005; 102: 16025-16030.
14. Brody LC, Conley M, Cox C, et al A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group. Am J Hum Genet. 2002; 71: 1207-1215.
15. Mills JL, Molloy AM, Parle-McDermott A, et al. Folate-related gene polymorphisms as risk factors for cleft lip and cleft palate. Birth Defects Res A Clin Mol Teratol. 2008; 82: 636-643.
16. Balduino Victorino D, de Godoy MF, Goloni-Bertollo EM, Pavarino EC. Genetic polymorphisms involved in folate metabolism and maternal risk for Down syndrome: a meta-Analysis. Dis Markers. 2014; 2014: 517504.
17. Meng J, Han L, Zhuang B. Association between MTHFD1 polymorphisms and neural tube defect susceptibility. J Neurol Sci. 2015; 348: 188-194.
18. Zheng J, Lu X, Liu H, et al. MTHFD1 polymorphism as maternal risk for neural tube defects: a meta-Analysis. Neurol Sci. 2015; 36: 607-616.
19. Yan J, Winter LB, Burns-Whitmore B, et al. Plasma choline metabolites associate with metabolic stress among young overweight men in a genotype-specific manner. Nutr Diabetes. 2012; 2: e49.
20. Mills JL, Fan R, Brody LC, et al. Maternal choline concentrations during pregnancy and choline-related genetic variants as risk factors for neural tube defects. Am J Clin Nutr. 2014; 100: 1069-1074.
21. Visentin CE, Masih S, Plumptre L, et al. Maternal choline status, but not fetal genotype, influences cord plasma choline metabolite concentrations. J Nutr. 2015; 145: 1491-1497.
22. Carolan-Olah M, Duarte-Gardea M, Lechuga J A critical review: early life nutrition and prenatal programming for adult disease. J Clin Nurs 2015. [Epub ahead of print
23. Medici V, Shibata NM, Kharbanda KK, et al. Maternal choline modifies fetal liver copper, gene expression, DNA methylation, and neonatal growth in the txj mouse model of Wilson disease. Epigenetics. 2014; 9: 286-296.
24. Neggers YH. Increasing prevalence, changes in diagnostic criteria, and nutritional risk factors for autism spectrum disorders. ISRN Nutr. 2014; 2014: 514026.
25. Barua S, Chadman KK, Kuizon S, et al. Increasing maternal or postweaning folic acid alters gene expression and moderately changes behavior in the offspring. PLoS One. 2014; 9: e101674.
26. Shorter KR, Felder MR, Vrana PB. Consequences of dietary methyl donor supplements: ismore always better? Prog Biophys Mol Biol. 2015; 118: 14-20.
27. Dominguez-Salas P, Moore SE, Baker MS, et al. Maternal nutrition at conception modulates DNA methylation of human metastable epialleles. Nat Commun. 2014; 5: 3746.
28. Clarke R, Halsey J, Lewington S, et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-Analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med. 2010; 170: 1622-1631.
29. Biselli PM, Guerzoni AR, de Godoy MF, et al. Genetic polymorphisms involved in folate metabolism and concentrations of methylmalonic acid and folate on plasma homocysteine and risk of coronary artery disease. J Thromb Thrombolysis. 2010; 29: 32-40.
30. Ghazouani L, Abboud N, Mtiraoui N, et al. Homocysteine and methylenetetrahydrofolate reductase C677T and A1298C polymorphisms in Tunisian patients with severe coronary artery disease. J Thromb Thrombolysis. 2009; 27: 191-197.
31. Ramkaran P, Phulukdaree A, Khan S, et al. Methylenetetrahydrofolate reductase C677T polymorphism is associated with increased risk of coronary artery disease in young South African Indians. Gene. 2015; 571: 28-32.
32. Matam K, Khan IA, Hasan Q, Rao P. Coronary artery disease and the frequencies of MTHFR and PON1 gene polymorphism studies in a varied population of Hyderabad, Telangana region in south India. J King Saud UnivV 27 2015; 143-150.
33. Hou X, Chen X, Shi J. Genetic polymorphism of MTHFR C677T and premature coronary artery disease susceptibility: a meta-Analysis. Gene. 2015; 565: 39-44.
34. Huo Y, Li J, Qin X, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA. 2015; 313: 1325-1335.
35. Trovato FM, Catalano D, Ragusa A, et al. Relationship of MTHFR gene polymorphisms with renal and cardiac disease. World J Nephrol. 2015; 4: 127-137.
36. Ganesh SK, Tragante V, Guo W, et al. Loci influencing blood pressure identified using a cardiovascular gene-centric array. Hum Mol Genet. 2013; 22: 1663-1678.
37. Xi B, Shen Y, Zhao X, et al. Association of common variants in/near six genes (ATP2B1, CSK, MTHFR, CYP17A1, STK39 and FGF5) with blood pressure/hypertension risk in Chinese children. J Hum Hypertens. 2014; 28: 32-36.
38. Benton MC, Lea RA, Macartney-Coxson D, et al. Mapping eQTLs in the Norfolk Island genetic isolate identifies candidate genes for CVD risk traits. Am J Hum Genet. 2013; 93: 1087-1099.
39. Yoneyama S, Guo Y, Lanktree MB, et al. Gene-centric meta-Analyses for central adiposity traits in up to 57 412 individuals of European descent confirm known loci and reveal several novel associations. Hum Mol Genet. 2014; 23: 2498-2510.
40. Al Rajabi A, Castro GS, da Silva RP, et al. Choline supplementation protects against liver damage by normalizing cholesterol metabolism in Pemt/Ldlr knockout mice fed a high-fat diet. J Nutr. 2014; 144: 252-257.
41. Zhao Y, Su B, Jacobs RL, et al. Lack of phosphatidylethanolamine Nmethyltransferase alters plasma VLDL phospholipids and attenuates atherosclerosis in mice. Arterioscler Thromb Vasc Biol. 2009; 29: 1349-1355.
42. Dumas ME, Barton RH, Toye A, et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci U S A. 2006; 103: 12511-12516.
43. Musso G, Gambino R, Cassader M. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med. 2011; 62: 361-380.
44. Ussher JR, Lopaschuk GD, Arduini A. Gut microbiota metabolism of L-carnitine and cardiovascular risk. Atherosclerosis. 2013; 231: 456-461.
45. Amirian ES, Petrosino JF, Ajami NJ, et al. Potential role of gastrointestinal microbiota composition in prostate cancer risk. Infect Agent Cancer. 2013; 8: 42.
46. Spencer MD, Hamp TJ, Reid RW, et al. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology. 2011; 140: 976-986.
47. Tang WH, Hazen SL. The contributory role of gut microbiota in cardiovascular disease. J Clin Invest. 2014; 124: 4204-4211.
48. Wang Z, Tang WH, Buffa JA, et al. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-Noxide. Eur Heart J. 2014; 35: 904-910.
49. Romano KA, Vivas EI, Amador-Noguez D, Rey FE. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. MBio. 2015; 6: e02481.
50. Shih DM, Wang Z, Lee R, et al. Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis. J Lipid Res. 2015; 56: 22-37.
51. Warrier M, Shih DM, Burrows AC, et al. The TMAO-generating enzyme flavin monooxygenase 3 is a central regulator of cholesterol balance. Cell Reports. 2015; 10: 326-338.
52. da Costa KA, Corbin KD, Niculescu MD, et al. Identification of new genetic polymorphisms that alter the dietary requirement for choline and vary in their distribution across ethnic and racial groups. FASEB J. 2014; 28: 2970-2978.
53. Schenkel LC, Singh RK, Michel V, et al. Mechanism of choline deficiency and membrane alteration in postural orthostatic tachycardia syndrome primary skin fibroblasts. FASEB J. 2015; 29: 1663-1675.
54. Rhee EP, Ho JE, Chen MH, et al A genome-wide association study of the human metabolome in a community-based cohort. Cell Metab. 2013; 18: 130-143.